Compounds > camptothecin
Page last updated: 2024-08-22

camptothecin and 10-methoxy-9-nitrocamptothecin

camptothecin has been researched along with 10-methoxy-9-nitrocamptothecin in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (66.67)29.6817
2010's2 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cheng, Y; He, Q; He, X; Hu, Y; Lu, W; Luo, P; Yang, B1
He, Q; Luo, P; Yang, B; Yang, X1
Diao, YY; Fang, QL; Gao, JQ; Han, M; He, CX; He, QJ; Hu, YZ; Liang, WQ; Xu, DH; Yang, B; Yang, XC1
He, Q; Lou, J; Lu, W; Yang, B; Yang, X; Zhang, C; Zhu, D; Zhu, H1
He, QJ; Lu, W; Luo, PH; Tu, CX; Wu, HH; Yang, B; Yang, XC; Zhou, XL; Zhu, DF; Zhu, H1
He, QJ; Jiang, H; Li, LJ; Yang, B; Zhang, C; Zhu, H; Zhu, Y1

Other Studies

6 other study(ies) available for camptothecin and 10-methoxy-9-nitrocamptothecin

ArticleYear
Potent antitumor activity of 10-methoxy-9-nitrocamptothecin.
    Molecular cancer therapeutics, 2006, Volume: 5, Issue:4

    Topics: Animals; Antineoplastic Agents, Phytogenic; Camptothecin; Carcinoma, Non-Small-Cell Lung; Cell Cycle; Cell Line, Tumor; Cell Survival; Humans; Lung Neoplasms; Male; Mice; Prostatic Neoplasms; Transplantation, Heterologous

2006
Antiangiogenesis response of endothelial cells to the antitumour drug 10-methoxy-9-nitrocamptothecin.
    Pharmacological research, 2006, Volume: 54, Issue:5

    Topics: Angiogenesis Inhibitors; Animals; Apoptosis; Camptothecin; Cell Line; Cell Movement; Cell Proliferation; Chick Embryo; Endothelial Cells; Enzyme Inhibitors; Humans; Topoisomerase I Inhibitors

2006
A novel camptothecin derivative incorporated in nano-carrier induced distinguished improvement in solubility, stability and anti-tumor activity both in vitro and in vivo.
    Pharmaceutical research, 2009, Volume: 26, Issue:4

    Topics: Animals; Antineoplastic Agents, Phytogenic; Camptothecin; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Chemistry, Pharmaceutical; Dose-Response Relationship, Drug; Drug Carriers; Drug Compounding; Drug Stability; Emulsifying Agents; Emulsions; Fluorescent Dyes; Glycerol; Hemolysis; Humans; Hydrogen-Ion Concentration; Hydrolysis; Kinetics; Male; Mice; Microscopy, Fluorescence; Nanostructures; Neoplasms; Oxazines; Particle Size; Rabbits; Solubility; Xenograft Model Antitumor Assays

2009
P53 and p38 MAPK pathways are involved in MONCPT-induced cell cycle G2/M arrest in human non-small cell lung cancer A549.
    Journal of cancer research and clinical oncology, 2010, Volume: 136, Issue:3

    Topics: Antineoplastic Agents; Camptothecin; Carcinoma, Non-Small-Cell Lung; Cell Cycle; Cell Division; Cell Line, Tumor; Cell Proliferation; G2 Phase; Humans; Lung Neoplasms; Models, Biological; Oncogene Protein v-akt; p38 Mitogen-Activated Protein Kinases; RNA, Small Interfering; Signal Transduction; Tumor Suppressor Protein p53

2010
Antimetastatic activity of MONCPT in preclinical melanoma mice model.
    Investigational new drugs, 2010, Volume: 28, Issue:6

    Topics: Animals; Camptothecin; Cell Adhesion; Cell Hypoxia; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Separation; Disease Models, Animal; Drug Screening Assays, Antitumor; Extracellular Signal-Regulated MAP Kinases; Female; Green Fluorescent Proteins; Hypoxia-Inducible Factor 1, alpha Subunit; Lung Neoplasms; Melanoma; Mice; Mice, Inbred C57BL; Neoplasm Invasiveness; Neoplasm Metastasis; Phosphorylation; Proto-Oncogene Proteins c-akt; Signal Transduction; Transduction, Genetic; Vascular Endothelial Growth Factor A

2010
MONCPT exerts anti-cancer activities via inducing G2/M arrest and apoptosis in human bladder cancer.
    Die Pharmazie, 2009, Volume: 64, Issue:12

    Topics: Animals; Antineoplastic Agents; Apoptosis; Blotting, Western; Camptothecin; Cell Cycle Proteins; Cell Division; Cell Line, Tumor; G2 Phase; Humans; Mice; Mice, Nude; Neoplasm Transplantation; Up-Regulation; Urinary Bladder Neoplasms; Xenograft Model Antitumor Assays

2009